Invasive Candida infections: the changing epidemiology.

Keyphrases

• Candida Glabrata 100%
• Invasive Candidiasis 100%
• Azole Antifungals 100%
• Changing Epidemiology 100%
• United States 50%
• Mortality Rate 50%
• Drug Resistance 50%
• Candida 50%
• Therapeutic Strategies 50%
• Most Common Cause 50%
• Patient Demographics 50%
• Treatment Options 50%
• Candida Albicans (C. albicans) 50%
• Candida Krusei 50%
• Antifungal Therapy 50%
• Underlying Disease 50%
• Fluconazole 50%
• Common Pathogens 50%
• Bloodstream Infection 50%
• Triazole 50%
• Non-albicans Candida 50%
• Unique Risk 50%
• Factor Combination 50%
• Fluconazole Prophylaxis 50%
• Therapeutic Risk 50%
• Attributable Mortality 50%
• Epidemiologic Change 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antifungal Agent 100%
• Candidiasis 100%
• Candida Albicans 66%
• Fluconazole 66%
• Pyrrole 66%
• Candida Glabrata 66%
• Disease 33%
• Prevalence 33%
• Drug Resistance 33%
• Mortality Rate 33%
• Infectious Agent 33%
• Candida 33%
• Bloodstream Infection 33%
• Triazole Derivative 33%
• Pichia kudriavzevii 33%